← Back to headlines
Biosergen Halts Development of Drug Candidate BSG005
Biopharmaceutical company Biosergen has announced a pause in the development of its drug candidate BSG005, a decision that could impact its pipeline and future prospects.
4 Apr, 19:01 — 4 Apr, 19:01
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Philippines receives diesel shipment from Malaysia
just now
DPWH Vows Completion of Stalled Laguna Medical Center Building by 2027
just now